Advertisement
Loading...

Astellas Pharma Inc.

ALPMY•PNK
Healthcare
Drug Manufacturers - General
$14.54
$0.03(0.17%)
U.S. Market is Open • 15:38

Astellas Pharma Inc. (ALPMY) Stock Overview

Explore Astellas Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap26.1B
P/E Ratio13.42
EPS (TTM)$1.02
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$15.15
3 Months$20.93
1 Year Target$14.50

ALPMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Astellas Pharma Inc. (ALPMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.42 and a market capitalization of 26.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.33%
5-Day Change
-2.78%
1-Month Change
-10.76%
3-Month Change
-10.04%
6-Month Change
19.08%
Year-to-Date (YTD) Change
9.59%
1-Year Change
54.44%
3-Year Change
-11.47%
5-Year Change
-5.37%
All-Time (Max) Change
89.64%

Contact Information

https://www.astellas.com
81 3 3244 3000
2-5-1, Nihonbashi-Honcho, Tokyo, NaN, 103-8411

Company Facts

14,754 Employees
IPO DateDec 29, 2009
CountryJP
Actively Trading

Frequently Asked Questions